Marc Goldman
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
-
- Genetic factors in colorectal cancer
Papers in
- Co-authors
- Scott Wadler (2 shared papers)Edward L. Schwartz (1 shared paper)Michael Rader (1 shared paper)V. Weinberg (1 shared paper)Loretta M. Itri (1 shared paper)P H Wiernik (1 shared paper)Matthew Zimmerman (1 shared paper)Jerrold L. Boxerman (2 shared papers)
- Journals
- Neurosurgery (2 papers)Journal of neurosurgery (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Marc Goldman
11 papers receiving 456 citations
Peers
Comparison fields: 5 of 59
- Oncology 265
- Pathology and Forensic Medicine 107
- Genetics 62
- Hepatology 39
- Otorhinolaryngology 18
Countries citing papers authored by Marc Goldman
This map shows the geographic impact of Marc Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Goldman more than expected).
Fields of papers citing papers by Marc Goldman
This network shows the impact of papers produced by Marc Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Goldman. The network helps show where Marc Goldman may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Goldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 271 | |
| 2 | Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma. | 1990 | 49 |
| 3 | 2013 | 40 | |
| 4 | 2011 | 32 | |
| 5 | 1993 | 26 | |
| 6 | 2006 | 18 | |
| 7 | 1992 | 15 | |
| 8 | 2008 | 11 | |
| 9 | 2006 | 3 | |
| 10 | 2012 | 2 | |
| 11 | 2006 | 2 |
About Marc Goldman
Marc Goldman is a scholar working on Surgery, Genetics, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 11 papers that have together received 469 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Meningioma and schwannoma management (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), EEG and Brain-Computer Interfaces (2 papers), Neuroscience and Neural Engineering (2 papers), Neurological disorders and treatments (2 papers) and Colorectal and Anal Carcinomas (2 papers). The work is most often cited by research in Oncology (265 citations), Pathology and Forensic Medicine (107 citations), Genetics (62 citations), Hepatology (39 citations) and Otorhinolaryngology (18 citations). Marc Goldman has collaborated with scholars based in United States. Frequent co-authors include Scott Wadler, Edward L. Schwartz, Michael Rader, V. Weinberg, Loretta M. Itri, P H Wiernik, Matthew Zimmerman, P H Wiernik, Jerrold L. Boxerman and William Lu. Their work appears in journals such as Neurosurgery, Journal of neurosurgery, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.